Iroko sets IPO range

Iroko Pharmaceuticals LLC (Philadelphia, Pa.) amended its IPO and now plans to sell 6.5 million shares at $14-$17 per share. At the $15.50 midpoint, the company would raise $100.8 million and be valued at $492.2 million. Jefferies; William Blair; Canaccord; and Oppenheimer are underwriters. Iroko filed to raise up to $145 million in the offering last month. ...